STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
116
13F, latest reported quarter
What the filings say about CNOB
Insiders, 180 days
+$36.0K net bought
1 buyer · 0% of sales under a 10b5-1 plan
ConnectOne Bancorp insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, ConnectOne Bancorp, Inc. insiders bought a net $36.0K of stock across 30 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 5.0% of the 137,383 shares held after it.
No other insider sold within 30 days.
116 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Bank President Magennis Elizabeth sold about $225.4K of CNOB on Oct 26, 2026, the largest insider sale at the company since 2023; 116 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 8.0% of the 21,145 shares held after it.
No other insider sold within 30 days.
116 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & Chief Credit Officer Javitz Joseph T. sold about $43.3K of CNOB on Sep 3, 2025, the largest insider sale at the company since 2023; 116 funds added in the latest 13F quarter.
30 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CNOB planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CNOB mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Hennessy Small Cap Financial Fund
$4.3M position · as of 2026-07-31
5.6%
HARTFORD SMALL CAP VALUE FUND
$5.2M position · as of 2026-07-31
1.7%
Nuveen Small Cap Value Fund
$4.7M position · as of 2026-07-31
1.6%
GATOR CAPITAL LONG/SHORT FUND
$842.1K position · as of 2026-07-31
1.1%
NORTH SQUARE KENNEDY MICROCAP FUND
$334.5K position · as of 2026-05-31
1.0%
Nomura VIP Small Cap Value Series
$18.8M position · as of 2026-06-30
1.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Frank Sorrentino III
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$4.4M
$4.8M
$1.2M
-10%
n/a
2024
$3.8M
$3.9M
$1.1M
+29%
+54%
2023
$3.5M
$3.2M
$1.0M
-2%
+24%
2022
$4.0M
$2.7M
$1.3M
-0%
+13%
2021
$3.1M
$5.3M
$1.0M
+32%
+32%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $36.0K bought by insiders over 180 days, 116 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM CNOB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM CNOB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$127.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CNOB
FY Dec 2025
$101.0M
FY Dec 2024
$56.9M
FY Dec 2023
$85.5M
FY Dec 2022
$173.5M
FY Dec 2021
$199.5M
Jun 2026
$33.7M
Mar 2026
$14.0M
Dec 2025
$46.1M
Sep 2025
$33.9M
Jun 2025
$6.4M
Mar 2025
$14.6M
Dec 2024
$30.0M
Sep 2024
-$15.6M
At each fiscal year end
Single quarter
Debt to equity
0.56x
long-term 2019-12-31 (79 months older than the period end) plus current 2022-03-31 (51 months older than the period end); equity 2026-06-30
Debt to equity CNOB
FY Dec 2025
0.58x
FY Dec 2024
0.73x
FY Dec 2023
0.75x
FY Dec 2022
0.77x
FY Dec 2021
4.64x
Jun 2026
0.56x
Mar 2026
0.57x
Dec 2025
0.58x
Sep 2025
0.59x
Jun 2025
0.61x
Mar 2025
0.73x
Dec 2024
0.73x
Sep 2024
0.73x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.15x
TTM operating cash flow over long-term 2019-12-31 (79 months older than the period end) plus current 2022-03-31 (51 months older than the period end)
Cash flow to debt CNOB
FY Dec 2025
0.12x
FY Dec 2024
0.07x
FY Dec 2023
0.10x
FY Dec 2022
0.19x
FY Dec 2021
0.04x
Jun 2026
0.15x
Mar 2026
0.12x
Dec 2025
0.12x
Sep 2025
0.10x
Jun 2025
0.04x
Mar 2025
0.06x
Dec 2024
0.07x
Sep 2024
0.06x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CNOB
FY Dec 2025
+5.7%
FY Dec 2024
+6.0%
FY Dec 2023
+7.3%
FY Dec 2022
+10.9%
FY Dec 2021
n/a
Jun 2026
+10.2%
Mar 2026
+6.9%
Dec 2025
+5.7%
Sep 2025
+4.4%
Jun 2025
+2.8%
Mar 2025
+6.2%
Dec 2024
+6.0%
Sep 2024
+6.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CNOB
FY Dec 2025
+0.7%
FY Dec 2024
+0.7%
FY Dec 2023
+0.9%
FY Dec 2022
+1.4%
FY Dec 2021
n/a
Jun 2026
+1.1%
Mar 2026
+0.8%
Dec 2025
+0.7%
Sep 2025
+0.5%
Jun 2025
+0.3%
Mar 2025
+0.8%
Dec 2024
+0.7%
Sep 2024
+0.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CNOB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CNOB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.77x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CNOB
FY Dec 2025
17.48x
FY Dec 2024
12.94x
FY Dec 2023
11.07x
FY Dec 2022
8.02x
FY Dec 2021
n/a
Jun 2026
10.96x
Mar 2026
15.47x
Dec 2025
17.48x
Sep 2025
20.01x
Jun 2025
26.62x
Mar 2025
13.14x
Dec 2024
12.94x
Sep 2024
14.40x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.2B
market value at close 2026-10-26 on 2026-08-04 shares, plus long-term 2019-12-31 (79 months older than the period end) plus current 2022-03-31 (51 months older than the period end), minus cash 2026-06-30
Enterprise value CNOB
FY Dec 2025
$1.8B
FY Dec 2024
$1.4B
FY Dec 2023
$1.6B
FY Dec 2022
$1.6B
FY Dec 2021
$6.2B
Jun 2026
$2.2B
Mar 2026
$1.9B
Dec 2025
$1.8B
Sep 2025
$1.6B
Jun 2025
$1.2B
Mar 2025
$1.6B
Dec 2024
$1.4B
Sep 2024
$1.6B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield CNOB
FY Dec 2025
+7.7%
FY Dec 2024
+6.5%
FY Dec 2023
+9.7%
FY Dec 2022
+18.3%
FY Dec 2021
+15.4%
Jun 2026
+7.6%
Mar 2026
+7.5%
Dec 2025
+7.7%
Sep 2025
+6.8%
Jun 2025
+4.0%
Mar 2025
+5.5%
Dec 2024
+6.5%
Sep 2024
+5.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.04x
P/E over trailing EPS growth of 251%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CNOB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.04x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CNOB ranks highest on institutional and government (63rd percentile) and insider conviction (61st), and lowest on financial health (23rd), among Banks peers.
Profitability
51
Inputs
Return on equity+10.2% · 48 pct, sector of 327
Return on assets+1.1% · 54 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
23
Inputs
Debt to equity0.56x · 27 pct, sector of 229
Cash flow to debt0.15x · 19 pct, sector of 198
Insider conviction
61
Inputs
Net Form 4 buying (codes P and S), 180d$36K · 76 pct, sector of 274
Insider buyers, 180d1 · 46 pct, sector of 274
Institutional and government
63
Inputs
Funds adding, latest quarter116 · 63 pct, sector of 257
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
36
Inputs
Short interest, % of float+4.3% · 36 pct, sector of 378
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Growth, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CNOB filings, in plain words
Are ConnectOne Bancorp insiders buying or selling CNOB?
In the 180 days to 2026-10-28, ConnectOne Bancorp insiders were net buyers, a net $36.0K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-28, ConnectOne Bancorp insiders were net buyers of CNOB, a net $36.0K across purchases and sales reported on Form 4 by 1 buyer. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.